FDA Inspection 652686 — Marlex Pharmaceuticals, Inc.

Marlex Pharmaceuticals, Inc. — FEI 1000121454

The FDA completed an inspection of Marlex Pharmaceuticals, Inc. on March 22, 2010 in New Castle, DE. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 22, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
New Castle, DE (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed